Regarding “Management of Dermatologic Events Associated with the Nectin-4–directed Antibody-Drug Conjugate Enfortumab Vedotin”

This letter to the editor remarks on a recently published article about dermatologic events induced by enfortumab vedotin, comparing results from other similar studies.

Detalles Bibliográficos
Autores principales: Ingen-Housz-Oro, Saskia, Thibault, Constance, Sohier, Pierre, Dupin, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526490/
https://www.ncbi.nlm.nih.gov/pubmed/36036595
http://dx.doi.org/10.1093/oncolo/oyac170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526490/
https://www.ncbi.nlm.nih.gov/pubmed/36036595
http://dx.doi.org/10.1093/oncolo/oyac170

Ejemplares similares